Document is current
Any future updates will be listed below
-
Authors
Fleseriu, Maria https://orcid.org/0000-0001-9284-6289
Varlamov, Elena V.
Hinojosa-Amaya, Jose M. https://orcid.org/0000-0002-6015-797X
Langlois, Fabienne
Melmed, Shlomo https://orcid.org/0000-0002-2355-3447
- License Information
-
More Information
Article History
Accepted: 22 June 2023
First Online: 3 August 2023
Competing interests
: M.F. has received grants to the institution from Crinetics, Novartis, Recordati, Sparrow, and Xeris (formerly Strongbridge), consulting fees from Crinetics, HRA Pharma, Novartis, Recordati, Sparrow, and Xeris (formerly Strongbridge), and serves as a member of the Board of Directors (non-compensated) for the Pituitary Society. E.V.V. has received grants to the institution from Recordati. F.L. has served as an adviser to Novartis and Recordati, and has served as a member of the Continuing Medical Education Committee for AMEQ (Association des Médecins Endocrinologues du Québec). S.M. has received grants to the institution from the US Food and Drug Administration and Recordati and non-financial support from Cyclacel, and serves as Secretary (non-compensated) for the Pituitary Society. J.M.H.-A. declares no competing interests.
